Guidewire Software Insider Sold Shares Worth $669,840, According to a Recent SEC Filing-March 2024-www.financetom.com

Guidewire Software Insider Sold Shares Worth $669,840, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Guidewire Software Insider Sold Shares Worth $669,840, According to a Recent SEC Filing

Aug 4, 2025 2:40 PM

05:08 PM EDT, 08/04/2025 (MT Newswires) -- John P Mullen, President, on August 01, 2025, sold 3,000 shares in Guidewire Software ( GWRE ) for $669,840. Following the Form 4 filing with the SEC, Mullen has control over a total of 143,489 common shares of the company, with 143,489 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1528396/000152839625000193/xslF345X05/wk-form4_1754340986.xml

Previous page： Phenixfin Insider Bought Shares Worth $618,422, According to a Recent SEC Filing Next page： Renovaro Regains Compliance With Nasdaq Listing Rule

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Phenixfin Insider Bought Shares Worth $618,422, According to a Recent SEC Filing

Dec 20, 2024

03:47 PM EST, 12/20/2024 (MT Newswires) -- David A Lorber, 10% Owner, Director, Chairman and CEO, on December 18, 2024, executed a purchase for 12,871 shares in Phenixfin ( PFX ) for $618,422. Following the Form 4 filing with the SEC, Lorber has control over a total of 223,805 shares of the company, with 138,854 shares held directly and 84,951...

Renovaro Regains Compliance With Nasdaq Listing Rule

Dec 20, 2024

03:55 PM EST, 12/20/2024 (MT Newswires) -- Renovaro ( RENB ) said Friday it regained compliance with Nasdaq's minimum bid price requirement. Shares of Renovaro ( RENB ) rose 7.1% in recent Friday trading. Price: 1.66, Change: +0.11, Percent Change: +7.12 ...

US FDA approves Vertex Pharma's triple combo cystic fibrosis treatment

Dec 20, 2024

Dec 20 (Reuters) - The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals' ( VRTX ) next-generation treatment for a rare and progressive genetic disease, the company said on Friday, expanding its dominance in the market for cystic fibrosis. ...

Market Chatter: Uber Pressed for More Transparency on Driver Pay by Investor Group

Dec 20, 2024

04:07 PM EST, 12/20/2024 (MT Newswires) -- Uber Technologies ( UBER ) faces a proposed shareholder resolution to be considered at its next annual meeting that would require the ride-hailing and delivery company to provide more detailed information about how its contract workers are compensated, according to a Bloomberg report on Friday. The resolution, submitted by SOC Investment Group, which...